Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Head & Neck 3Thoracic 2Plasma cell 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Lymphoma 2983Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Lymphoma, Non-Hodgkin 2269Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1848Lymphoma, Large B-Cell, Diffuse 1785Leukemia 1341Hodgkin Disease 1293Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 979Burkitt Lymphoma 956Multiple Myeloma 866Lymphoma, B-Cell, Marginal Zone 853Recurrence 841Lymphoma, B-Cell 756Myelodysplastic Syndromes 683Neoplasms 595Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 352Hematologic Neoplasms 351Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Interventions

Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Humoral Hypercalcemia Of Malignancy × Lymphoid × Clear all
NCT00896454 2018-10-17

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Amgen

Phase 2 Completed
33 enrolled 22 charts
BreastGastrointestinalGenitourinaryHead & NeckLymphoidPlasma cellThoracic

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Hodgkin Disease, Hypercalcemia, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Parathyroid Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡